A pharmaceutical firm had forecast that one of its leading products would continue to grow at 20% per annum for the next 10-15 years.

To meet demand, it planned the building of a new £40m facility. However, coming to a decision regarding the precise site of the facility proved to be a major challenge, with a range of sites presenting different risks.

Marsh helped the firm define the detailed decision criteria on which to assess each site objectively and developed a model to score each site against these predetermined performance indicators.

Managers were able to make an informed and balanced decision, and were affirmed in their decision when it was revealed that the annual running costs of the selected site were £1.2m less than the proposed alternatives.

Name (required)

Email (required)

Website

Enter the code shown above:

Notify me of followup comments via e-mail